Skip to content

Author

R. Kälviäinen

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Quantifying extra‐lesional interhemispheric cortical asymmetry in focal cortical dysplasia type II

Abstract Objective Focal cortical dysplasia type II (FCDII) is a cortical malformation representing a common cause of surgically treatable drug‐resistant epilepsy. We studied whether FCDII disrupts normal structural interhemispheric asymmetry beyond the lesion location and quantified these asymmetries derived from structural magnetic resonance imaging (MRI) between individuals with FCDII and healthy controls (HC) as well as within FCDII subtypes using surface‐based morphometry (SBM). Methods Using an open MRI dataset from University Hospital Bonn, we processed T1‐weighted images from HC and individuals with FCDII aged over 15 years at the time of scan. We designed a three‐stage workflow consisting of SBM using FreeSurfer, visual inspection of atlas‐based cortical parcellations, and lesion projection. We extracted five cortical measures of intensity, thickness, volume, curvature, and surface area from 34 regions of interest (ROIs) and computed unsigned interhemispheric asymmetry indices beyond the lesion location. Results The majority of FCDII lesions annotated in the original dataset were located in the frontal lobe (64.0%). Compared to the HC, individuals with MRI‐diagnosed FCDII showed significantly reduced unsigned interhemispheric intensity asymmetry across parietal, temporal, and occipital cortices (q < 0.001). We observed an increase in the unsigned interhemispheric volume asymmetry in the lateral orbitofrontal cortex and in the unsigned interhemispheric surface‐area asymmetry in the inferior temporal cortex for FCDII compared to HC (q < 0.001). Subtype analyses revealed greater unsigned interhemispheric intensity asymmetry in caudal anterior cingulate and superior temporal cortices in FCDIIb compared with FCDIIa (q < 0.001). Conversely, precentral unsigned surface‐area and volume asymmetries were smaller in FCDIIb relative to FCDIIa (q < 0.001). We observed no significant differences for unsigned interhemispheric cortical thickness and curvature asymmetries after multiple‐comparison corrections. Significance SBM‐derived interhemispheric asymmetry captures cortical alterations in FCDII beyond the focal lesions. Observed differences in group‐level unsigned interhemispheric intensity, volume, and surface‐area asymmetry indicated cortical alterations that are consistent with distributed cortical involvement between FCDIIa and FCDIIb. These findings may enhance presurgical evaluation by highlighting cortical areas outside the primary lesion that could contribute to seizure generation and achieving seizure‐freedom after the operation. Plain Language Summary Focal cortical dysplasia type II (FCDII) is a malformation of cortical development associated with drug‐resistant epilepsies. FCDII may disrupt normal cortical interhemispheric asymmetries which are understudied in focal, extratemporal epilepsies. We discovered that individuals with FCDII display altered structural cortical interhemispheric asymmetries in intensity, volume, and surface area compared to healthy volunteers, with each FCDII subtype exhibiting a distinct pattern of disrupting the natural asymmetries. Since extra‐lesional abnormalities may contribute to incomplete seizure control after surgery, these interhemispheric asymmetry findings could provide complementary information for presurgical evaluations.

Faeze Heidari, M. Torkamani-Azar, J. Tohka et al. · 0 citations
Open access Aug 2026

Bridging the Gap Between Depression and Epilepsy: A Call for Integrated Neuropsychiatric Care

Abstract “Brain health” encompasses key functions such as cognition, emotion, and behaviour, and is increasingly relevant given its role across neurological and psychiatric conditions. One of these, depression is the most common psychiatric comorbidity in people with epilepsy (PWE). When unrecognized and untreated, depression is associated with increased seizure severity and poorer treatment response, significantly impacting patients’ prognosis and quality of life; conversely, the rate of epilepsy is 2-fold higher in individuals with incident depression compared to those without depression. Several studies have confirmed a strong bidirectional relationship between epilepsy and depression; an advisory panel of psychiatrists and neurologists with expertise in epilepsy and mood disorders convened for a virtual meeting held in 2024 to assess the impact of the interplay between these two conditions. A comprehensive, interdisciplinary approach to discussion was adopted to address challenges in diagnosing and managing depression in PWE, focusing on early intervention, patient education, and tailored treatments strategies; additionally, the meeting emphasized the importance of integrated care between neurologists and psychiatrists to address this unmet medical need. The authors identified depression in PWE as being underdiagnosed due to overlapping symptoms, stigma, and limited psychiatric care integration. Management is challenging as some antiseizure medication worsen depression and certain antidepressants may lower the seizure threshold, requiring careful selection and monitoring to balance efficacy and safety. Potential interactions between these medicines underscore the importance of carefully selecting therapeutic combinations to minimize adverse effects. Effective management involves an interdisciplinary approach, integrating neurologists and psychiatrists. Key strategies include early screening, psychoeducation, a personalized approach to pharmacological and nonpharmacological treatment, and increased awareness among healthcare providers, patients, and caregivers regarding the overlap of neurological and psychiatric disorders. Furthermore, educational resources, as well as digital tools, can help inform and educate patients and caregivers on holistic brain health management.

P. Brambilla, R. Kälviäinen, Bettina Schmitz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.